Trust Company of Vermont’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$13.5K Hold
200
﹤0.01% 810
2025
Q3
$14.7K Hold
200
﹤0.01% 779
2025
Q2
$10.4K Hold
200
﹤0.01% 810
2025
Q1
$12.8K Hold
200
﹤0.01% 733
2024
Q4
$9.56K Hold
200
﹤0.01% 773
2024
Q3
$11.4K Hold
200
﹤0.01% 739
2024
Q2
$10.5K Hold
200
﹤0.01% 686
2024
Q1
$8.14K Buy
+200
New +$7.5K ﹤0.01% 706
2023
Q4
Sell
-200
Closed -$7.64K 844
2023
Q3
$7.64K Hold
200
﹤0.01% 677
2023
Q2
$7.21K Hold
200
﹤0.01% 710
2023
Q1
$7.64K Hold
200
﹤0.01% 737
2022
Q4
$11.4K Hold
200
﹤0.01% 667
2022
Q3
$8K Hold
200
﹤0.01% 756
2022
Q2
$9K Buy
+200
New +$8.65K ﹤0.01% 699
2022
Q1
Sell
-200
Closed -$8K 490
2021
Q4
$8K Buy
+200
New +$7.47K ﹤0.01% 687
2021
Q3
Sell
-200
Closed -$9K 478
2021
Q2
$9K Hold
200
﹤0.01% 651
2021
Q1
$8K Hold
200
﹤0.01% 651
2020
Q4
$9K Hold
200
﹤0.01% 639
2020
Q3
$5K Hold
200
﹤0.01% 662
2020
Q2
$5K Hold
200
﹤0.01% 683
2020
Q1
$4K Hold
200
﹤0.01% 769
2019
Q4
$4K Hold
200
﹤0.01% 807
2019
Q3
$3K Hold
200
﹤0.01% 887
2019
Q2
$3K Hold
200
﹤0.01% 900
2019
Q1
$3K Hold
200
﹤0.01% 854
2018
Q4
$3K Hold
200
﹤0.01% 886
2018
Q3
$4K Hold
200
﹤0.01% 939
2018
Q2
$3K Hold
200
﹤0.01% 1000
2018
Q1
$4K Hold
200
﹤0.01% 852
2017
Q4
$4K Buy
+200
New +$3.68K ﹤0.01% 865

Other funds holding HALO

Trust Company of Vermont's HALO Position: Q4 2025 in Review

Trust Company of Vermont held its Halozyme (HALO) position steady in Q4 2025 at 200 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Trust Company of Vermont first reported a position in HALO in Q4 2017 and has held it in 30 quarters since. The position peaked at $14.7K in Q3 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • Trust Company of Vermont held 200 shares of Halozyme worth $13.5K as of Q4 2025.
  • Trust Company of Vermont left its Halozyme share count unchanged in Q4 2025.
  • Halozyme made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #810 holding.
  • Trust Company of Vermont first reported a position in Halozyme in Q4 2017 and has held it in 30 quarters since.
  • Trust Company of Vermont's Halozyme position peaked at $14.7K in Q3 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.